Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL142822 | 0.91 | ACHE (0.33) | ACHEBBOX1 | |
| SCHEMBL361078 | 0.87 | ACHE (0.34) | ACHEBBOX1 | |
| Hydrochloric Acid SCHEMBL27740878 | 0.87 | BBOX1 (0.31) | BBOX1 | |
| Water SCHEMBL5407242 | 0.84 | ACHE (0.33) | ACHEBBOX1 | |
| Iodide SCHEMBL28293289 | 0.84 | ACHE (0.33) | ACHEBBOX1 | |
| Bromide SCHEMBL4276591 | 0.84 | ACHE (0.37) | ACHEBBOX1 | |
| Fluoride Ion SCHEMBL6689085 | 0.84 | ACHE (0.33) | ACHEBBOX1 | |
| Ammonia Solution, Strong SCHEMBL6558011 | 0.84 | ACHE (0.33) | ACHEBBOX1 | |
| SCHEMBL5447792 | 0.81 | ACHE (0.31) | ACHEBBOX1 | |
| SCHEMBL8019334 | 0.81 | ACHE (0.31) | ACHEBBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6646083-B2 | Such as diallyldimethylammonium chloride crosslinked with 1,3-bis(N,N-diallylpiperid-1-ium-4-yl) propane dichloride; thermal stability; use as polymer catalyst for producing glycols from oxiranes; ion exchange catalyst | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-11-11 | — | — | US | disclosed |
| US-20030130510-A1 | Process for producing N-hydroxyalkyl compound, and tris (2-hydroxyethyl) isocyanurate composition | NIPPON SHOKUBAI CO., LTD. | 2003-07-10 | — | — | US | disclosed |
| EP-1323706-A1 | Process for producing N-hydroxyalkyl compound, and tris(2-hydroxyethyl) isocyanurate composition | Nippon Shokubai Co., Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-20020028887-A1 | Crosslinked polymer, method for manufacturing it and use thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130510-A1 | Process for producing N-hydroxyalkyl compound, and tris (2-hydroxyethyl) isocyanurate composition | HAAO, ALKBH3, FTO | ACHE 1208/4885BBOX1 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.